Hot Products
Catalog No. | Information |
CFN00166 | Calystegine A3 Calystegines A3, B2, and C1 are glycosidase inhibitors. Calystegines A3 and B2 can effectively stabilize β-glucocerebrosidase, and consequently increase intracellular β-glucocerebrosidase activities in N370S fibroblasts. |
CFN00169 | Calystegine A5 Reference standards. |
CFN00164 | Calystegine B1 Calystegine B1 is a noncompetitive inhibitor of rice alpha-glucosidase, with a Ki value of 0.9 +/- 0.1 microM. Calystegine B1 and Calystegine C1 are potent competitive inhibitors of the bovine, human, and rat beta-glucosidase activities, with Ki values of 150, 10, and 1.9 microM. |
CFN00161 | Calystegine B2 Calystegine B2 can inhibit the alpha-galactosidase and enzymes beta-glucosidase activities. |
CFN00162 | Calystegine B3 Calystegine B3 is a highly specific inhibitor for Man2C1 among various α-mannosidases prepared from rat liver, it could thus serve as a potent tool for the development of a highly specific in vivo inhibitor for Man2C1. |
CFN00163 | Calystegine B4 Calystegine B4 inhibits almond beta-glucosidase and pig kidney trehalase in a competitive manner, with a Ki value of 7.3 microM and 1.2 microM, respectively. |
CFN99693 | Calyxin B Calyxin B exhibits potent activity against human HT-1080 fibrosarcoma cells with an ED50 value of 0.69 microM. A methylated product of calyxin A and an epimeric mixture of Calyxin B, showed greatly reduced activity suggesting that phenolic hydroxyl groups are involved in the inhibitory activity. |
CFN96017 | Camaldulenic acid Standard reference |
CFN90992 | Camellianin A Camellianin A has anticancer activity, it can inhibit the proliferation of the human hepatocellular liver carcinoma Hep G2 and human breast adenocarcinoma MCF-7 cell lines in a dose-dependent manner and induce the significant increase of the G0/G1 cell population. Camellianin A also shows angiotensin converting enzyme (ACE) inhibitory activity. |
CFN93559 | Camelliaside A Camelliaside A is a natural product from Camellia oleifera Abel. |